MedTrace Logo

The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China

NCT03044847 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 3800

Last updated 2021-07-29

No results posted yet for this study

Summary

The purpose of this study is to establish the large COPD cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices and to monitor and improve clinical outcomes in this disease.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

COPD group

The treatments will be determined by their treating physicians and no additional investigational drugs will be applied to the patients included in this study.

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    lead OTHER

Principal Investigators

  • Kewu Huang, M.D. · Beijing Chao Yang Hospital

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03044847 on ClinicalTrials.gov